3/6/2013

Some physicians at the Cleveland Clinic support FDA efforts to restrict opioid drug prescriptions while others are concerned the plan could harm patients who need long-term pain relief. Supporters of restrictive prescribing say misperceptions among clinicians lead to doses that are too high, but registered nurse and pain researcher Esther Bernhofer says proposed limits could "backfire and only harm the people who really need professional help."

Related Summaries